Considerations for Preclinical Safety Assessment of Adeno-Associated Virus Gene Therapy Products
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Considerations for Preclinical Safety Assessment of Adeno-Associated Virus Gene Therapy Products
Authors
Keywords
-
Journal
TOXICOLOGIC PATHOLOGY
Volume 46, Issue 8, Pages 1020-1027
Publisher
SAGE Publications
Online
2018-10-08
DOI
10.1177/0192623318803867
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN
- (2018) Christian Hinderer et al. HUMAN GENE THERAPY
- The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL/6J Mice
- (2018) Juliette Hordeaux et al. MOLECULAR THERAPY
- Pharmacology of Recombinant Adeno-associated Virus Production
- (2018) Magalie Penaud-Budloo et al. Molecular Therapy-Methods & Clinical Development
- Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction
- (2018) Zachary Fitzpatrick et al. Molecular Therapy-Methods & Clinical Development
- Emerging Issues in AAV-Mediated In Vivo Gene Therapy
- (2018) Pasqualina Colella et al. Molecular Therapy-Methods & Clinical Development
- Strategy to detect pre-existing immunity to AAV gene therapy
- (2017) L Falese et al. GENE THERAPY
- Direct Intracranial Injection of AAVrh8 Encoding Monkey β-N-Acetylhexosaminidase Causes Neurotoxicity in the Primate Brain
- (2017) Diane Golebiowski et al. HUMAN GENE THERAPY
- Overcoming the Host Immune Response to Adeno-Associated Virus Gene Delivery Vectors: The Race Between Clearance, Tolerance, Neutralization, and Escape
- (2017) Federico Mingozzi et al. Annual Review of Virology
- Recombinant AAV Integration Is Not Associated With Hepatic Genotoxicity in Nonhuman Primates and Patients
- (2016) Irene Gil-Farina et al. MOLECULAR THERAPY
- Adeno-Associated Virus at 50: A Golden Anniversary of Discovery, Research, and Gene Therapy Success—A Personal Perspective
- (2015) Eric Hastie et al. HUMAN GENE THERAPY
- Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy
- (2015) Randy J. Chandler et al. JOURNAL OF CLINICAL INVESTIGATION
- Determination of Anti-Adeno-Associated Virus Vector Neutralizing Antibody Titer with anIn VitroReporter System
- (2015) Amine Meliani et al. Human Gene Therapy Methods
- Perinatal systemic gene delivery using adeno-associated viral vectors
- (2014) Rajvinder Karda et al. Frontiers in Molecular Neuroscience
- Immune responses to AAV vectors: overcoming barriers to successful gene therapy
- (2013) F. Mingozzi et al. BLOOD
- Selection and evaluation of clinically relevant AAV variants in a xenograft liver model
- (2013) Leszek Lisowski et al. NATURE
- A largely random AAV integration profile after LPLD gene therapy
- (2013) Christine Kaeppel et al. NATURE MEDICINE
- The Committee for Advanced Therapies' of the European Medicines Agency Reflection Paper on Management of Clinical Risks Deriving from Insertional Mutagenesis
- (2013) Alessandro Aiuti et al. Human Gene Therapy Clinical Development
- Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
- (2008) Carmela Zincarelli et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now